Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Fifty Years of Tobacco Carcinogenesis Research: From Mechanisms to Early Detection and Prevention of Lung Cancer

(2014) S. S. Hecht et al.   Cancer Prevention Research

The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex

(2013) A. Z. X. Zhu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6

(2012) A. Joseph Bloom et al.   HUMAN MOLECULAR GENETICS

Glucuronidation of trans-3′-hydroxycotinine by UGT2B17 and UGT2B10

(2012) Gang Chen et al.   Pharmacogenetics and Genomics

Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption

(2012) A. Joseph Bloom et al.   Pharmacogenetics and Genomics

Haplotypes with Copy Number and Single Nucleotide Polymorphisms in CYP2A6 Locus Are Associated with Smoking Quantity in a Japanese Population

(2012) Natsuhiko Kumasaka et al.   PLoS One

Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure?

(2011) Jingzhu Wang et al.   BIOMARKERS

Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk

(2011) Catherine A. Wassenaar et al.   JNCI-Journal of the National Cancer Institute

A linear complexity phasing method for thousands of genomes

(2011) Olivier Delaneau et al.   NATURE METHODS

UGT2B10 Genotype Influences Nicotine Glucuronidation, Oxidation, and Consumption

(2010) J. Z. Berg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Glucuronidation Genotypes and Nicotine Metabolic Phenotypes: Importance of Functional UGT2B10 and UGT2B17 Polymorphisms

(2010) G. Chen et al.   CANCER RESEARCH

A map of human genome variation from population-scale sequencing

(2010) Richard M. Durbin et al.   NATURE

Nicotine Addiction

(2010) Neal L. Benowitz   NEW ENGLAND JOURNAL OF MEDICINE

Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer

(2009) Kiersten S. Derby et al.   INTERNATIONAL JOURNAL OF CANCER

Nicotine Metabolism in African Americans and European Americans: Variation in Glucuronidation by Ethnicity and UGT2B10 Haplotype

(2009) J. Z. Berg et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers

(2009) Hans J. Roethig et al.   NICOTINE & TOBACCO RESEARCH

A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies

(2009) Bryan N. Howie et al.   PLoS Genetics

Optimal Serum Cotinine Levels for Distinguishing Cigarette Smokers and Nonsmokers Within Different Racial/Ethnic Groups in the United States Between 1999 and 2004

(2008) Neal L. Benowitz et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Nicotine Metabolism in Three Ethnic/Racial Groups with Different Risks of Lung Cancer

(2008) K. S. Derby et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Glucuronidation of Tobacco-Specific Nitrosamines by UGT2B10

(2008) G. Chen et al.   DRUG METABOLISM AND DISPOSITION

Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines

(2008) Gang Chen et al.   Pharmacogenetics and Genomics